Sumitomo Mitsui Trust Holdings, Inc. Royalty Pharma PLC Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $168 Billion
- Q3 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 1,101,641 shares of RPRX stock, worth $43.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,101,641
Previous 894,303
23.18%
Holding current value
$43.1 Million
Previous $32.2 Million
20.62%
% of portfolio
0.02%
Previous 0.02%
Shares
15 transactions
Others Institutions Holding RPRX
# of Institutions
534Shares Held
303MCall Options Held
1.34MPut Options Held
252K-
Morgan Stanley New York, NY44.2MShares$1.73 Billion0.1% of portfolio
-
Capital International Investors Los Angeles, CA27.2MShares$1.07 Billion0.16% of portfolio
-
Black Rock Inc. New York, NY23MShares$901 Million0.01% of portfolio
-
Baillie Gifford & CO17.4MShares$680 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$478 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $17.1B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...